Answers are grounded in this paper and cite their sources.
In addition to cytotoxic effects, anticancer agents can exert multiple immunomodulatory functions. We have recently described the molecular mechanisms whereby bleomycin can 1) promote endoplasmic reticulum stress, causing the immunogenic death of cancer cells and hence strengthening antitumor CD8+ T cell responses; and 2) induce the secretion of transforming growth factor β (TGFβ), which stimulates regulatory T cells. This suggests that bleomycin may be favorably combined with TGFβ-targeting strategies.
No takes yet. Share an insight, caveat, or question.
Mignot et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: